ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

Heidelberger Wins $100,000 Award

September 17, 1982

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

In Brief: King ACCC President, Fleming President Elect; Wyngaarden Says He Doesn’t Oppose Panel

March 25, 1988

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010